Merck & Co (MRK)
62.84
+0.21 +0.34%
NYSE
Jul 24, 13:02
Delayed 2m
USD
Merck & Co Cash from Investing (TTM):
-1.758B for March 31, 2017View 4,000+ financial data types
Browse...
View Full Chart
Merck & Co Cash from Investing (TTM) Chart
Export Data
Save Image
Print Image
For advanced charting, view our full-featured
Fundamental Chart
Merck & Co Historical Cash from Investing (TTM) Data
View and export this data going back to 1984.
Start your Free Trial
Export Data
Date Range:
| Data for this Date Range | |
|---|---|
| March 31, 2017 | -1.758B |
| Dec. 31, 2016 | -3.21B |
| Sept. 30, 2016 | -1.264B |
| June 30, 2016 | -435.00M |
| March 31, 2016 | 3.588B |
| Dec. 31, 2015 | -4.758B |
| Sept. 30, 2015 | 3.063B |
| June 30, 2015 | -598.00M |
| March 31, 2015 | -3.172B |
| Dec. 31, 2014 | -374.00M |
| Sept. 30, 2014 | -6.401B |
| June 30, 2014 | -4.716B |
| March 31, 2014 | -5.802B |
| Dec. 31, 2013 | -3.148B |
| Sept. 30, 2013 | -8.723B |
| June 30, 2013 | -8.525B |
| March 31, 2013 | -7.688B |
| Dec. 31, 2012 | -6.805B |
| Sept. 30, 2012 | -4.091B |
| June 30, 2012 | -2.515B |
| March 31, 2012 | -3.265B |
| Dec. 31, 2011 | -2.89B |
| Sept. 30, 2011 | -2.213B |
| June 30, 2011 | -1.756B |
| March 31, 2011 | -244.00M |
| Dec. 31, 2010 | -3.497B |
| Sept. 30, 2010 | -15.35B |
| June 30, 2010 | -3.537B |
| March 31, 2010 | -1.382B |
| Dec. 31, 2009 | 3.156B |
| Sept. 30, 2009 | 15.57B |
| June 30, 2009 | 281.10M |
| March 31, 2009 | -2.347B |
| Dec. 31, 2008 | -1.834B |
| Sept. 30, 2008 | -2.232B |
| June 30, 2008 | 975.80M |
| March 31, 2008 | 374.20M |
| Dec. 31, 2007 | -2.81B |
| Sept. 30, 2007 | -3.656B |
| June 30, 2007 | -5.554B |
| March 31, 2007 | -7.67B |
| Dec. 31, 2006 | -4.884B |
| Sept. 30, 2006 | 1.564B |
| June 30, 2006 | 3.275B |
| March 31, 2006 | 4.981B |
| Dec. 31, 2005 | 2.267B |
| Sept. 30, 2005 | -2.344B |
| June 30, 2005 | -2.255B |
| March 31, 2005 | -2.480B |
| Dec. 31, 2004 | -1.638B |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About Cash From Investing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More
Advertisement
MRK Cash from Investing (TTM) Benchmarks
| Companies | |
|---|---|
| Abbott Laboratories | -6.628B |
| Celgene | -2.552B |
| Johnson & Johnson | -4.16B |
MRK Cash from Investing (TTM) Range, Past 5 Years
| Minimum | -8.723B | Sep 2013 |
| Maximum | 3.588B | Mar 2016 |
| Average | -3.411B |
MRK Cash from Investing (TTM) Excel Add-In Codes
- Metric Code: cash_investing_ttm
- Latest data point: =YCP("MRK", "cash_investing_ttm")
- Last 5 data points: =YCS("MRK", "cash_investing_ttm", -4)
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
MRK News
Analyst Actions: BMO Capital Markets Cuts Merck PT to $73 vs $74; Maintains Outperform Rating
MT Newswires 07/24 11:56 ET
MT Newswires 07/24 11:56 ET
Merck & Company Launches Its Tumor Necrosis Factor Blocker Renflexis in U.S.
MT Newswires 07/24 09:04 ET
MT Newswires 07/24 09:04 ET
Advertisement
